Active

RING PHARMA

Switched

BE0472540052

Rechtspersoon Public limited company 1 establishment

Kerkeblokstraat 5-7, 1850 Grimbergen Markt- en opinieonderzoek

Active for

26 year, 1 month

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.

Gross margin

€ 22,429

▼ 41% vs 2024

Profit

Caution

€ -104,944

▼ 2184% vs 2024

Debts

High

€ 1.6 million

▼ 23% vs 2024

RING PHARMA from Grimbergen, company number BE0472540052, closed financial year 2025 with a result of € -104,944 after tax. For that financial year RING PHARMA recorded a gross margin of € 22,429 and equity of € -2,412. Compared with financial year 2024, the result moved from € 5,037 to € -104,944. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What happened at RING PHARMA?

What happened at RING PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 104,944 (▼ 2184% vs 2024). Source: NBB ↗
  • New establishment in Grimbergen. KBO
  • Start of the company according to the CBE. KBO

In short

From € 17,361 loss in 2021 to € 104,944 loss in 2025.

Best year ever: 2024, with € 5,037 profit.

A new publication or filing at RING PHARMA? We notify you, reason included.

Follow RING PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Marc Crepel

Behind RING PHARMA is Marc Crepel. Marc Crepel is also behind INSIGO, 'T WIT PAARD, MAGISTRA BUILDING COMPANY, TOF Belgium Real Estate and ARO.

See the full network in the app

Directors

According to the 2025 annual accounts

Marc Crepel

Director

Also active at: INSIGO, 'T WIT PAARD, MAGISTRA BUILDING COMPANY +6 more

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkeblokstraat 5-7

1850 Grimbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0472.540.052
VAT number
BE 0472.540.052
Registered office
Kerkeblokstraat 5-7, 1850 Grimbergen
Names & denominations
RING PHARMA
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
7 August 2000
Peppol
Active · Active since 17 Nov 2025
Activities · NACE

Markt- en opinieonderzoek

Marktonderzoekbureaus

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Handelsbemiddeling in meubels, huishoudelijke artikelen en ijzerwaren

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What is the enterprise number of RING PHARMA?
The enterprise number of RING PHARMA is BE0472540052.
What is the address of RING PHARMA?
The registered office of RING PHARMA is located at Kerkeblokstraat 5-7, 1850 Grimbergen.
When was RING PHARMA founded?
RING PHARMA was founded on 7 August 2000.
What is the main activity of RING PHARMA?
The main activity of RING PHARMA is "Markt- en opinieonderzoek" (NACE code 73200).
Does RING PHARMA have a website?
No website is currently known for RING PHARMA.
How much profit did RING PHARMA make in 2025?
RING PHARMA recorded a loss after taxes of € 104,944 in financial year 2025.
What is the revenue of RING PHARMA?
As a small company, RING PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 22,429.
Where can I find the annual accounts of RING PHARMA?
RING PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of RING PHARMA?
According to the 2025 annual accounts, the directors of RING PHARMA are: Marc Crepel.
Who owns RING PHARMA?
Behind RING PHARMA is Marc Crepel. Marc Crepel is also behind INSIGO, 'T WIT PAARD, MAGISTRA BUILDING COMPANY, TOF Belgium Real Estate and ARO.